PURE Bioscience (OTCMKTS:PURE) Stock Short Interest Drops 54.8%

PURE Bioscience (OTCMKTS:PURE – Get Free Report) was the recipient of a significant decline in short interest during the month of October. As of October 30th, there was short interest totaling 1,982 shares, a decline of 54.8% from the October 15th total of 4,381 shares. Based on an average daily volume of 26,909 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company’s stock are short sold.

PURE Bioscience Stock Performance

Shares of OTCMKTS:PURE remained flat at $0.07 during midday trading on Friday. The stock had a trading volume of 9,187 shares, compared to its average volume of 21,797. The company has a market capitalization of $9.10 million, a P/E ratio of -3.50 and a beta of 0.34. PURE Bioscience has a 1 year low of $0.04 and a 1 year high of $0.10. The stock’s 50 day moving average price is $0.07 and its 200 day moving average price is $0.07.

About PURE Bioscience

(Get Free Report)

PURE Bioscience develops and commercializes antimicrobial products based on silver dihydrogen citrate (SDC), a proprietary formulation designed to control bacteria and other microorganisms. The company focuses on applications where surface hygiene and food safety are important. Its offerings include SDC-based disinfectant and sanitizer products for hard surfaces, including products intended for food-processing and food-service environments. PURE Bioscience also pursues commercial partnerships to market its technology and products.

Featured Stories

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.